Showing results (181-190 of 498) with videos related to
Sort By:
Pageof 50
Haematologica|December 6, 2006
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosisVittorio Perfetti, Salvatore Siena, Giovanni Palladini, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2020
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathyLuis F Maia, Aleksandra Maceski, Isabel Conceição, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2019
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeMerrill D Benson, Joel N Buxbaum, David S Eisenberg, et al.Arthritis and Rheumatism|October 1, 2004
First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndromeLaura Obici, Carlo Manno, Andrea Onetti Muda, et al.Haematologica|June 29, 2023
Amyloidogenic light chains impair plasma cell survivalMarjorie Pick, Eyal Lebel, Sharona Elgavish, et al.Biochimica Et Biophysica Acta|September 13, 2005
Proteomics of beta2-microglobulin amyloid fibrilsMonica Stoppini, Palma Mangione, Maria Monti, et al.Annals of Hematology|September 10, 2008
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomideGiovanni Palladini, Paola Russo, Francesca Lavatelli, et al.Seminars in Hematology|May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathyShirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.The Canadian Journal of Cardiology|May 4, 2012
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular functionAlessandra Barassi, Raffaele Pezzilli, Antonio M Morselli-Labate, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 10, 2002
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.Pageof 50